DEEP-DIVE-GLOBAL-CANAL
24.11.2022 12:23:38 CET | Business Wire | Press release
Covering more than 100 cities in five continents in more than one year, the Deep Dive Global Canal Rowing Action concluded its last leg of the world tour with a global rowing relay in around 20 cities worldwide recently, highlighted the action with fruitful achievements.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221124005072/en/
Jean-Christophe Rolland, World Rowing Federation president (L3) delivers special honor certificate to Wang Shi (R3), honorary president of Asian Rowing Federation and the action’s team leader in Sharm El-Sheikh during the 2022 United Nations Climate Change Conference (COP27) on 14 Nov. 2022. (Photo: Business Wire)
“On the same day, we held great celebrations both in Yangzhou, a major city along the ancient China’s Grand Canal, and in Cairo, one of the most famous cities along the Nile, the longest river worldwide,” said Feng Nan, president of Deep Dive Sports and Health of China and the organizer of the action. “The two cities thousands of kilometers apart, together with other cities participated and witnessed the successful action, making a clear sign that action has won wide endorsement."
The Deep Dive Action, initially co-organized by the World Historic and Cultural Canal Cities Cooperation Organization (WCCO), an international organization headquartered in Yangzhou, and the Shenzhen Foundation for International Exchange and Cooperation (SFIEC) of China, is aiming to promote the idea of sports, health and environmental protection by holding rowing events in canal cities around the world.
“It’s a milestone in the history of rowing. It’s also a great worldwide environmental awareness campaign,” Feng stressed.
Starting from China’s Grand Canal in September 2021, the campaign has been held successfully on the Potomac River in Washington, the Thames in London, the Seine in Paris, the Donau in Vienna, etc., attracting more than 2,000 international paddlers.
Jean-Christophe Rolland, World Rowing Federation president, highly praised the event. “More important was the powerful message carried out by this mission, which connected and inspired the rowing family to make a difference in this regard,” he stated in a signed letter.
At a side event held in Sharm El-Sheikh during the 2022 United Nations Climate Change Conference (COP27), Rolland also delivered his appreciation especially to Wang Shi, honorary president of Asian Rowing Federation and the action’s team leader, “It is great to see your incredible environmental advocacy, initiated during your presidency at the Asian Rowing Federation, and continuing since.”
“The action connected different cities and different cultures, and raised environmental awareness of many people under the slogan of ‘zero carbon, zero waste and clean water’,” Feng added, “A new plan of the campaign for the next year is in the pipeline.”
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221124005072/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
